Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 31M | 36M | 31M | 33M | 36M | 29M |
| Cost of revenue | 22M | 26M | 22M | 24M | 27M | 20M |
| Gross profit | 8M | 9M | 9M | 9M | 9M | 9M |
| Research and development | 282,610 | 283,867 | 484,502 | 316,726 | 451,975 | 530,797 |
| Selling, general and administrative | 2M | 3M | 3M | 3M | 3M | 3M |
| Operating expenses | 9M | 9M | 10M | 10M | 9M | 9M |
| Operating income | −691,409 | 369,723 | −832,338 | −1M | −65,826 | −450,362 |
| Pre-tax income | −1M | −68,467 | −2M | −2M | −430,711 | −321,830 |
| Income tax | 24,678 | 2M | −214,576 | −739,530 | 267,537 | −298,415 |
| Net income | −969,405 | −2M | −1M | −815,557 | −550,137 | −23,415 |
| Earnings per share | −0.50 | −0.86 | −0.64 | −0.07 | −0.29 | 0.09 |
| Earnings per share, diluted | −0.50 | −0.86 | −0.64 | −0.07 | −0.29 | 0.08 |
| Weighted average shares | 2M | 2M | 2M | 10M | 2M | 2M |
| Weighted average shares, diluted | 2M | 2M | 2M | 10M | 2M | 2M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3M | 2M | 2M | 3M | 1M | 5M | 3M | 1M |
| Receivables | 14M | 14M | 18M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −325,713 | — | — | −7M | — | — |
| Depreciation and amortisation | 177,128 | 182,759 | 163,931 | 147,287 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 16M |
| 19M |
| 20M |
| 19M |
| 18M |
| Inventory | 14M | 15M | 12M | 13M | 13M | 14M | 14M | 13M |
| Current assets | 51M | 52M | 53M | 49M | 47M | 53M | 52M | 48M |
| Property, plant and equipment | 4M | 4M | 4M | 4M | 4M | 4M | 3M | 3M |
| Total assets | 68M | 70M | 73M | 72M | 68M | 75M | 75M | 70M |
| Current liabilities | 44M | 44M | 44M | 41M | 37M | 43M | 40M | 34M |
| Short-term debt | 13M | 12M | 14M | 13M | 13M | 15M | 12M | 10M |
| Total liabilities | 54M | 54M | 55M | 51M | 48M | 54M | 52M | 47M |
| Equity | 16M | 17M | 20M | 20M | 21M | 22M | 23M | 23M |
| Shares outstanding | 2M | 2M | 2M | 2M | 10M | 2M | 10M | 10M |
| Shares issued | 2M | 2M | 2M | 2M | 10M | 2M | 10M | 10M |
| 125,244 |
| 111,568 |
| Share-based compensation | −116,394 | — | — | 76,306 | — | — |
| Capital expenditure | 79,726 | — | — | 349,875 | — | — |
| Investing cash flow | −79,726 | — | — | −450,155 | — | — |
| Financing cash flow | 1M | — | — | −1M | — | — |